Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-19
DOI
10.3389/fimmu.2020.00909
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations
- (2020) Colin Havenar-Daughton et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
- (2020) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania
- (2019) Zacchaeus Anywaine et al. JOURNAL OF INFECTIOUS DISEASES
- Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
- (2019) Christopher A. Green et al. JOURNAL OF INFECTION
- A review of 65 years of human adenovirus seroprevalence
- (2019) Franck J. D. Mennechet et al. Expert Review of Vaccines
- Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus
- (2019) Myung Hee Kim et al. PLoS One
- Human adenovirus type 26 uses sialic acid–bearing glycans as a primary cell entry receptor
- (2019) Alexander T. Baker et al. Science Advances
- The potential of adenoviral vaccine vectors with altered antigen presentation capabilities
- (2019) Lasse Neukirch et al. Expert Review of Vaccines
- Innate immunity to adenovirus: lessons from mice
- (2019) Svetlana Atasheva et al. FEBS LETTERS
- Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice
- (2019) Carly M. Bliss et al. Molecular Therapy-Methods & Clinical Development
- Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations
- (2019) N. C. Salisch et al. npj Vaccines
- Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine
- (2018) Lynda Coughlan et al. Cell Host & Microbe
- Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine
- (2018) Martinus A.H. Capelle et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56
- (2018) Margaret R. Duffy et al. JOURNAL OF GENERAL VIROLOGY
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding
- (2018) Natalie F. Nidetz et al. VIROLOGY
- Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
- (2018) Carly M. Bliss et al. Scientific Reports
- Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination
- (2018) Wenli Zhang et al. Human Gene Therapy Methods
- Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor
- (2018) Nicole Stichling et al. PLoS Pathogens
- A bovine adenoviral vector-based H5N1 influenza vaccine provides enhanced immunogenicity and protection at a significantly lower dose compared to a human adenoviral vector-based vaccine in a mouse model
- (2018) Ekramy E. Sayedahmed et al. Molecular Therapy-Methods & Clinical Development
- Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
- (2018) L. Coughlan et al. EBioMedicine
- A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
- (2018) Benoit Callendret et al. PLoS One
- Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses
- (2018) Benedict R. Halbroth et al. Scientific Reports
- First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
- (2018) Alfred B. Tiono et al. PLoS One
- A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis
- (2018) Chuan Wang et al. PLoS Neglected Tropical Diseases
- Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
- (2017) Alessandra Vitelli et al. Expert Review of Vaccines
- Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
- (2017) Carly M. Bliss et al. MOLECULAR THERAPY
- Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques
- (2017) Diane L. Bolton et al. VACCINE
- Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo
- (2017) Sam Afkhami et al. VACCINE
- Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages
- (2017) Mareike D. Maler et al. mBio
- An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity
- (2017) Wenli Zhang et al. Cell Reports
- Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
- (2017) Victorine A. Mensah et al. Frontiers in Immunology
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity
- (2016) Daniela Anghelina et al. JOURNAL OF VIROLOGY
- Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
- (2016) Muhammed O Afolabi et al. MOLECULAR THERAPY
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus sensing by the immune system
- (2016) Svetlana Atasheva et al. Current Opinion in Virology
- Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
- (2015) Kylie M. Quinn et al. JOURNAL OF CLINICAL INVESTIGATION
- Adenoviral vectors as novel vaccines for influenza
- (2015) Lynda Coughlan et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection
- (2015) M Jeyanathan et al. Mucosal Immunology
- Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
- (2015) Christopher A. Green et al. Science Translational Medicine
- Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
- (2015) Caroline Ogwang et al. Science Translational Medicine
- Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
- (2015) Matthew D. J. Dicks et al. Scientific Reports
- Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
- (2015) C A Green et al. BMJ Open
- Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
- (2015) Ivy Wilkinson-Ryan et al. PLoS One
- Innate Immunity to Adenovirus
- (2014) Rodinde Hendrickx et al. HUMAN GENE THERAPY
- Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo
- (2014) D. M. Appledorn et al. JOURNAL OF IMMUNOLOGY
- Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
- (2014) Susanne H. Hodgson et al. JOURNAL OF INFECTIOUS DISEASES
- Enhanced Vaccine-Induced CD8+ T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain
- (2014) Alexandra J. Spencer et al. PLoS One
- Adenovirus-Based Vaccine against Listeria monocytogenes: Extending the Concept of Invariant Chain Linkage
- (2013) S. Jensen et al. JOURNAL OF IMMUNOLOGY
- Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization
- (2013) K. M. Quinn et al. JOURNAL OF IMMUNOLOGY
- A Direct and Versatile Assay Measuring Membrane Penetration of Adenovirus in Single Cells
- (2013) M. Suomalainen et al. JOURNAL OF VIROLOGY
- Adenovirus Detection by the cGAS/STING/TBK1 DNA Sensing Cascade
- (2013) E. Lam et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
- (2013) Marc Gurwith et al. LANCET INFECTIOUS DISEASES
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
- (2013) Teresa Lambe et al. Scientific Reports
- Molecular evolution of human adenoviruses
- (2013) Christopher M. Robinson et al. Scientific Reports
- Combined Fiber Modifications Both to Target αvβ6 and Detarget the Coxsackievirus–Adenovirus Receptor Improve Virus Toxicity Profiles In Vivo but Fail to Improve Antitumoral Efficacy Relative to Adenovirus Serotype 5
- (2012) Lynda Coughlan et al. HUMAN GENE THERAPY
- Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
- (2012) Angela C. Bradshaw et al. JOURNAL OF CONTROLLED RELEASE
- Type I IFN Induced by Adenovirus Serotypes 28 and 35 Has Multiple Effects on T Cell Immunogenicity
- (2012) M. J. Johnson et al. JOURNAL OF IMMUNOLOGY
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
- (2012) Lindsey R. Baden et al. JOURNAL OF INFECTIOUS DISEASES
- Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
- (2012) A. Duerr et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
- (2012) Dan H. Barouch et al. JOURNAL OF INFECTIOUS DISEASES
- Overreliance on the Hexon Gene, Leading to Misclassification of Human Adenoviruses: Fig 1
- (2012) Gurdeep Singh et al. JOURNAL OF VIROLOGY
- Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
- (2012) Pablo Penaloza-MacMaster et al. JOURNAL OF VIROLOGY
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+T Cells Induced by Different Adenovirus Vectors
- (2012) Wendy G. Tan et al. JOURNAL OF VIROLOGY
- Spatiotemporal Dynamics of Adenovirus Membrane Rupture and Endosomal Escape
- (2012) O. Maier et al. JOURNAL OF VIROLOGY
- Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys
- (2012) Jeffrey E. Teigler et al. JOURNAL OF VIROLOGY
- Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery
- (2012) Lynda Coughlan et al. MOLECULAR THERAPY
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
- (2012) S. Colloca et al. Science Translational Medicine
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Drifting Motions of the Adenovirus Receptor CAR and Immobile Integrins Initiate Virus Uncoating and Membrane Lytic Protein Exposure
- (2011) Christoph J. Burckhardt et al. Cell Host & Microbe
- Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain
- (2011) M. Mikkelsen et al. JOURNAL OF IMMUNOLOGY
- Identification of Adenovirus Serotype 5 Hexon Regions That Interact with Scavenger Receptors
- (2011) R. Khare et al. JOURNAL OF VIROLOGY
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Cross-dressers turn on T cells
- (2011) Jonathan W. Yewdell et al. NATURE
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
- (2011) Nancy J Sullivan et al. NATURE MEDICINE
- Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF
- (2011) Anja Krause et al. VACCINE
- CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells
- (2010) J. D. Bassett et al. BLOOD
- Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
- (2010) R. Alba et al. BLOOD
- Production of adenovirus vectors and their use as a delivery system for influenza vaccines
- (2010) Sai V Vemula et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Quality of the Transgene-Specific CD8+ T Cell Response Induced by Adenoviral Vector Immunization Is Critically Influenced by Virus Dose and Route of Vaccination
- (2010) P. J. Holst et al. JOURNAL OF IMMUNOLOGY
- CD8+ T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+ Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling
- (2010) R. W. B. Lindsay et al. JOURNAL OF IMMUNOLOGY
- Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine Vectors
- (2010) E. G. Rhee et al. JOURNAL OF VIROLOGY
- Route of Adenovirus-Based HIV-1 Vaccine Delivery Impacts the Phenotype and Trafficking of Vaccine-Elicited CD8+ T Lymphocytes
- (2010) D. R. Kaufman et al. JOURNAL OF VIROLOGY
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
- (2010) Dan H Barouch et al. NATURE MEDICINE
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass
- (2010) R. Alcock et al. Science Translational Medicine
- Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28
- (2010) Christoph A. Kahl et al. VACCINE
- Adenoviral Producer Cells
- (2010) Imre Kovesdi et al. Viruses-Basel
- Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
- (2010) Lynda Coughlan et al. Viruses-Basel
- Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
- (2010) Angela C. Bradshaw et al. PLoS Pathogens
- A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry
- (2010) Harald Wodrich et al. PLoS Pathogens
- Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
- (2009) C. Harro et al. Clinical and Vaccine Immunology
- Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1α-Mediated Proinflammatory Macrophage Response In Vivo
- (2009) Nelson C. Di Paolo et al. IMMUNITY
- Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN
- (2009) W. C. Adams et al. JOURNAL OF GENERAL VIROLOGY
- Antiviral Antibodies Target Adenovirus to Phagolysosomes and Amplify the Innate Immune Response
- (2009) A. K. Zaiss et al. JOURNAL OF IMMUNOLOGY
- TRIF, and TRIF-Interacting TLRs Differentially Modulate Several Adenovirus Vector-Induced Immune Responses
- (2009) D.M. Appledorn et al. Journal of Innate Immunity
- Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus
- (2009) J. D. Finn et al. JOURNAL OF VIROLOGY
- Scavenger Receptor A: A New Route for Adenovirus 5
- (2009) Hidde J. Haisma et al. MOLECULAR PHARMACEUTICS
- Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
- (2009) Kara L O'Brien et al. NATURE MEDICINE
- Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
- (2009) A. Benlahrech et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
- (2008) Simon N. Waddington et al. CELL
- Inhibition of Melanoma Growth by Targeting of Antigen to Dendritic Cells via an Anti-DEC-205 Single-Chain Fragment Variable Molecule
- (2008) T. S. Johnson et al. CLINICAL CANCER RESEARCH
- Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults
- (2008) Frances H. Priddy et al. CLINICAL INFECTIOUS DISEASES
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
- (2008) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adenoviruses: update on structure and function
- (2008) W. C. Russell JOURNAL OF GENERAL VIROLOGY
- Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
- (2008) Z. Xu et al. JOURNAL OF VIROLOGY
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
- (2008) Daniel A. Muruve et al. NATURE
- Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications
- (2007) Zachary C. Hartman et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now